Gustav Ullenhag
- Oncology top 2%
- Immunology top 5%
- Molecular Biology
- Genetics top 10%
- Ophthalmology top 2%
- Co-authors
- Angelica LoskogEmma ErikssonJessica WentheSandra IrenaeusSzilvia MosolitsHåkan MellstedtJan‐Erik FrödinRoger Olofsson Bagge
- Topics
- Immunotherapy and Immune Responses (39 papers)CAR-T cell therapy research (31 papers)Cancer Immunotherapy and Biomarkers (22 papers)
- Cited by
- OncologyImmunologyOphthalmology
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- SwedenDenmarkUnited Kingdom
In The Last Decade
Gustav Ullenhag
90 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 83
- Oncology 1.1k
- Immunology 837
- Molecular Biology 633
- Genetics 291
- Ophthalmology 186
Countries citing papers authored by Gustav Ullenhag
This map shows the geographic impact of Gustav Ullenhag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustav Ullenhag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustav Ullenhag more than expected).
Fields of papers citing papers by Gustav Ullenhag
This network shows the impact of papers produced by Gustav Ullenhag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustav Ullenhag. The network helps show where Gustav Ullenhag may publish in the future.
Co-authorship network of co-authors of Gustav Ullenhag
This figure shows the co-authorship network connecting the top 25 collaborators of Gustav Ullenhag. A scholar is included among the top collaborators of Gustav Ullenhag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustav Ullenhag. Gustav Ullenhag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 3 | |
| 5 | 36 | |
| 6 | 8 | |
| 7 | 15 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 33 | |
| 11 | 7 | |
| 12 | 11 | |
| 13 | 8 | |
| 14 | 12 | |
| 15 | 52 | |
| 16 | 116 | |
| 17 | 37 | |
| 18 | 30 | |
| 19 | 29 | |
| 20 | 13 |
About Gustav Ullenhag
Gustav Ullenhag is a scholar working on Oncology, Immunology and Ophthalmology, having authored 97 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (39 papers), CAR-T cell therapy research (31 papers) and Cancer Immunotherapy and Biomarkers (22 papers). The work is most often cited by research in Oncology (1.1k citations), Immunology (837 citations) and Ophthalmology (186 citations). Gustav Ullenhag has collaborated with scholars based in Sweden, Denmark and United Kingdom. Frequent co-authors include Angelica Loskog, Emma Eriksson, Jessica Wenthe, Sandra Irenaeus, Szilvia Mosolits, Håkan Mellstedt, Jan‐Erik Frödin, Roger Olofsson Bagge, Lars Ny and Anna Dimberg. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.